Boston Scientific CorporationBSXNYSE
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
3Y CAGR+58.8%
5Y CAGR+26.4%
Year-over-Year Change
Operating cash flow minus capital expenditures
3Y CAGR
+58.8%/yr
Annual compound
5Y CAGR
+26.4%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
3.2x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $3.66B | +38.3% |
| 2024 | $2.65B | +55.3% |
| 2023 | $1.70B | +86.3% |
| 2022 | $914.00M | -30.5% |
| 2021 | $1.32B | +16.3% |
| 2020 | $1.13B | -17.7% |
| 2019 | $1.38B | +23016.7% |
| 2018 | $-6.00M | -100.5% |
| 2017 | $1.11B | +85.7% |
| 2016 | $596.00M | - |